TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24111623

Group type: EXPERIMENTAL
Intervention: 5-step proactive coping intervention targeting proactive coping skills
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Booster phase of the intervention
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Medical variables assessed at T1 and T4
Number of subjects: 141
Study: 20138095

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Epinastine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 18775608

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (inactive substance)
Number of subjects: 74
Study: 16650417

Group type: EXPERIMENTAL
Intervention: Patients with PCOS
Number of subjects: 159

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 159
Study: 12879220

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (60 min per day, 3 days a week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (usual activities)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0
Study: 11694861

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg twice daily)
Number of subjects: 56
Study: 10771880

Group type: EXPERIMENTAL
Intervention: IPV (Inactivated Polio Vaccine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 doses of IPV starting from birth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPV/OPV at birth followed by 3 doses of OPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Some vaccine at birth (IPV or OPV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 doses of IPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPV or OPV at birth
Number of subjects: 0
Study: 8183102

Group type: COMPARATOR
Intervention: Sodium concentration of 0 mmol.l‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium concentration of 25 mmol.l‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium concentration of 50 mmol.l‐1
Number of subjects: 6
Study: 3351300

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg (acute study)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nisoldipine 25 mg (chronic study)
Number of subjects: 19
Study: 30669291

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (Fortaleça sua Saúde program)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 548
Study: 28688136

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional palpation technique
Number of subjects: 84
Study: 25823403

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl) for 5 minutes followed by EDTA for 10 minutes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaOCl + triple antibiotic paste (TAP) for 4 weeks followed by EDTA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaOCl + diluted triple antibiotic paste (DTAP) for 4 weeks followed by EDTA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaOCl + calcium hydroxide (Ca[OH]2) for 4 weeks followed by EDTA
Number of subjects: 50

Group type: COMPARATOR
Intervention: Untreated dentin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaOCl + EDTA-treated dentin
Number of subjects: 50
Study: 23307511

Group type: EXPERIMENTAL
Intervention: Tα1 administration for 2 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no Tα1 administration)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tα1 administration
Number of subjects: 8
Study: 21768905

Group type: EXPERIMENTAL
Intervention: Combat Application Tourniquet (CAT) self-applied at mid-thigh level
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combat Application Tourniquet (CAT) applied by a researcher
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Emergency and Military Tourniquet (EMT) applied
Number of subjects: 24
Study: 19152135

Group type: EXPERIMENTAL
Intervention: Tc-99 m tetrofosmin SPECT myocardial perfusion imaging (MPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise treadmill testing (ETT)
Number of subjects: 0
Study: 16738024

Group type: EXPERIMENTAL
Intervention: Behavioral styles after 2 weeks
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Behavioral styles after 15 weeks
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Participants' perceptions of their own personalities
Number of subjects: 102
Study: 15492601

Group type: EXPERIMENTAL
Intervention: Large volume tap water gastric lavage prior to esophagogastroduodenoscopy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Esophagogastroduodenoscopy alone
Number of subjects: 39
Study: 11406837

Group type: EXPERIMENTAL
Intervention: Education package for the treatment of menorrhagia given to doctors at a primary care level
Number of subjects: 0

Group type: COMPARATOR
Intervention: No education package (control group)
Number of subjects: 0
Study: 9265910

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8219431

Group type: EXPERIMENTAL
Intervention: Clonidine with behavior modification
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clonidine without behavior modification
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo with behavior modification
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo without behavior modification
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 30470924

Group type: EXPERIMENTAL
Intervention: Standardized immediate postpartum contraceptive counseling intervention emphasizing healthy birth spacing and LARC
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Immediate postpartum availability of the contraceptive implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Subjects who desired the IUD
Number of subjects: 100
Study: 29578520

Group type: EXPERIMENTAL
Intervention: Mobile game-based virtual reality program for upper extremity rehabilitation
Number of subjects: 0
Study: 27187436

Group type: EXPERIMENTAL
Intervention: Healthcare providers (HCPs)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Parents of children aged 6-10 and 11-14 years
Number of subjects: 500
Study: 24057996

Group type: EXPERIMENTAL
Intervention: Topiramate (TOP)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Topiramate/Nicotine patch (TOP/NIC)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 57
Study: 23018337

Group type: EXPERIMENTAL
Intervention: Culture Conducive to Women's Academic Success (CCWAS) measure
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: CCWAS dimensions: equal access, work-life balance, freedom from gender biases, supportive leadership
Number of subjects: 133
Study: 20028376

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs)
Number of subjects: 7461

Group type: EXPERIMENTAL
Intervention: Total serum IgE
Number of subjects: 7461
Study: 17986289

Group type: EXPERIMENTAL
Intervention: Fluorescence diagnosis (FD)
Number of subjects: 46

Group type: COMPARATOR
Intervention: White light (WL)
Number of subjects: 46
Study: 16471192

Group type: EXPERIMENTAL
Intervention: DPOAE amplitude and slope of DPOAE input/output function after noise exposure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SISI test results
Number of subjects: 30
Study: 11960561

Group type: EXPERIMENTAL
Intervention: Backpack positioned at T7 with loads of 3%, 5%, or 10% of body weight
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Backpack loads (3%, 5%, or 10% of body weight)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Unloaded standing posture (baseline)
Number of subjects: 250
Study: 10394049

Group type: EXPERIMENTAL
Intervention: Cladribine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7676386

Group type: EXPERIMENTAL
Intervention: Xylitol-containing dentifrice (9.7%)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-xylitol-containing fluoride dentifrice
Number of subjects: 70
Study: 2372267

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily + Aspirin 600 mg three times a day
Number of subjects: 69

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 69
Study: 6108263

Group type: EXPERIMENTAL
Intervention: Azatadine maleate/pseudoephedrine sulfate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31241208

Group type: EXPERIMENTAL
Intervention: Happiness induction
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Sadness induction
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (non-ED)
Number of subjects: 49
Study: 29987365

Group type: EXPERIMENTAL
Intervention: Hypoxic training (HT) for 30 min/day, 5 days/week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normoxic training (NT) for 30 min/day, 5 days/week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypoxic control (HC) for 30 min/day, 5 days/week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normoxic control (NC) for 30 min/day, 5 days/week for 4 weeks
Number of subjects: 60
Study: 27133033

Group type: EXPERIMENTAL
Intervention: Endurance exercise (group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endurance-strength exercise (group B)
Number of subjects: 44
Study: 24592904

Group type: EXPERIMENTAL
Intervention: Interseptal bone reduction combined with conventional orthodontic fixed appliance
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional extraction (control)
Number of subjects: 18
Study: 22344575

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 15 mg/week
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 20620742

Group type: EXPERIMENTAL
Intervention: High-flavanol intervention (HiFI) [375 mg]
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-flavanol intervention (LoFI) [9 mg]
Number of subjects: 16
Study: 17079067

Group type: EXPERIMENTAL
Intervention: CPREzy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: CPREzy (Group 2A; n = 36)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Classic ECC (Group 2B; n = 55)
Number of subjects: 202
Study: 16296913

Group type: EXPERIMENTAL
Intervention: Homeopathic remedy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 11927115

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (Mirena)
Number of subjects: 256
Study: 9797692

Group type: EXPERIMENTAL
Intervention: Pamidronate 300 mg daily
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Pamidronate 150 mg daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study: 7572771

Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation at He‐7 acupoint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-acupuncture control point stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acupuncture stimulation at LI‐4 acupoint
Number of subjects: 0
Study: 2202024

Group type: EXPERIMENTAL
Intervention: Sprotte cannula (24 G)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Quincke cannula (25 G)
Number of subjects: 500
Study: 64803

Group type: EXPERIMENTAL
Intervention: Bendrofluazide 5 mg and 10 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prazosin 2 mg three times daily (rising to 5 mg if required)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All three drugs (beta blockade, bendrofluazide, and prazosin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Beta blockade
Number of subjects: 20
Study: 30793440

Group type: EXPERIMENTAL
Intervention: Highest quartile of oxidized low-density lipoprotein (oxLDL)
Number of subjects: 3019

Group type: EXPERIMENTAL
Intervention: Highest quartile of oxidized low-density lipoprotein:high-density lipoprotein (oxLDL:HDL)
Number of subjects: 3019

Group type: EXPERIMENTAL
Intervention: Highest quartile of oxidized low-density lipoprotein:low-density lipoprotein (oxLDL:LDL)
Number of subjects: 3019
Study: 29999596

Group type: EXPERIMENTAL
Intervention: nHFOV
Number of subjects: 30

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 30
Study: 26934136

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 24462960

Group type: EXPERIMENTAL
Intervention: 1.7% hypertonic saline solution supplemented with 40 mg furosemide (salt infusion group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Glucose supplemented with 40 mg furosemide (glucose infusion group)
Number of subjects: 44
Study: 22955125

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (120 mg tablet, EGb‐761) twice a day for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo tablet twice a day for 12 weeks
Number of subjects: 120
Study: 20028712

Group type: EXPERIMENTAL
Intervention: Memantine 10 mg twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17684983

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch
Number of subjects: 2

Group type: COMPARATOR
Intervention: 10% albumin solution
Number of subjects: 2
Study: 16084882

Group type: EXPERIMENTAL
Intervention: G972A variant of insulin receptor substrate‐1 (IRS‐1) in women with PCOS
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (women without PCOS)
Number of subjects: 120
Study: 12601100

Group type: EXPERIMENTAL
Intervention: Pergolide (0.15 to 0.45 mg per day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 10029283

Group type: EXPERIMENTAL
Intervention: Natural IFNalpha, 10 MU, i.m. daily for 2 consecutive weeks and then three times per week for the subsequent 14 weeks (total dose 560 MU)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Natural IFNalpha treatment
Number of subjects: 50
Study: 8677203

Group type: EXPERIMENTAL
Intervention: Men after myocardial infarction
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sons of patients
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (men)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (sons)
Number of subjects: 33
Study: 1996510

Group type: EXPERIMENTAL
Intervention: Printed reminders for all eligible patients
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Printed reminders for half of eligible patients
Number of subjects: 686

Group type: COMPARATOR
Intervention: No printed reminders
Number of subjects: 686
Study: 6095655

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg as a single nighttime dose
Number of subjects: 109
Study: 31605515

Group type: EXPERIMENTAL
Intervention: HAL-based walking therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 54
Study: 28393417

Group type: EXPERIMENTAL
Intervention: Fosaprepitant (150 mg d1) in combination with granisetron and dexamethasone
Number of subjects: 645

Group type: COMPARATOR
Intervention: Aprepitant (125 mg d1; 80 mg d2-d3) in combination with granisetron and dexamethasone
Number of subjects: 645
Study: 25844619

Group type: EXPERIMENTAL
Intervention: Whey protein supplement (45-g daily)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Isocaloric maltodextrin supplement (control)
Number of subjects: 208
Study: 24517028

Group type: EXPERIMENTAL
Intervention: Paracetamol (1.0 g) co-administered with ferrous sulphate (300 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Paracetamol (1.0 g) alone
Number of subjects: 10
Study: 22314714

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation (CSM)
Number of subjects: 12
Study: 19508653

Group type: EXPERIMENTAL
Intervention: Endurance training (E)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Strength training (S)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training (SE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 63
Study: 17544558

Group type: EXPERIMENTAL
Intervention: Leaflet alone
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Leaflet plus motivational quiz
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Leaflet plus implementation intention prompt
Number of subjects: 503

Group type: COMPARATOR
Intervention: No leaflet (control)
Number of subjects: 503
Study: 15321812

Group type: EXPERIMENTAL
Intervention: Cooked, puréed sweet potatoes (750 microg RE/d)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cooked, puréed Indian spinach (Basella alba) (750 microg RE/d)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Retinyl palmitate (750 microg RE/d)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Synthetic beta-carotene (750 microg RE/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-vitamin A control group (0 microg RE/d)
Number of subjects: 14
Study: 12215864

Group type: EXPERIMENTAL
Intervention: Active gallium-arsenide (Ga-As) laser therapy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Amitriptyline therapy (10 mg daily at bedtime for 8 weeks)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 75
Study: 9831123

Group type: EXPERIMENTAL
Intervention: FC‐23 at 30% concentration
Number of subjects: 5

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 5

Group type: COMPARATOR
Intervention: 40% N2O
Number of subjects: 5
Study: 7526675

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Sematilide
Number of subjects: 78
Study: 2782506

Group type: EXPERIMENTAL
Intervention: Television plus manual condition
Number of subjects: 50000

Group type: COMPARATOR
Intervention: Manual alone
Number of subjects: 50000

Group type: COMPARATOR
Intervention: Other conditions designed to supplement the manual plus television
Number of subjects: 50000
Study: 780001

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate aerosol, 800 mcg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29788815

Group type: EXPERIMENTAL
Intervention: Magnesium loading dose (7.5 g of magnesium sulfate in 500 mL normal saline as intravenous infusion over an 8-hour period)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Magnesium loading dose
Number of subjects: 70
Study: 30648561

Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pre-nephrectomy transplant evaluation
Number of subjects: 27

Group type: COMPARATOR
Intervention: cT1a renal parenchymal mass
Number of subjects: 27
Study: 28222818

Group type: EXPERIMENTAL
Intervention: Combined pricing and communications intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pricing intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Communications intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 25384603

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) group, 150 mg/kg IV bolus at anaesthetic induction followed by continuous infusion at 150 mg/kg per day for 24 hours.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no NAC treatment)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: NAC group
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 22530610

Group type: EXPERIMENTAL
Intervention: Exercise and isoflavones (Ex-Iso; n = 26)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Exercise and placebo (Ex-Pla; n = 28)
Number of subjects: 54
Study: 21514083

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 1800
Study: 19966634

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (stimulator ON)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sacral nerve stimulation (stimulator OFF)
Number of subjects: 19
Study: 17428318

Group type: EXPERIMENTAL
Intervention: Telephone coaching intervention (8 sessions over 18 months plus usual care)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Usual care from GPs
Number of subjects: 546
Study: 15311010

Group type: EXPERIMENTAL
Intervention: Spiral stent
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard stent
Number of subjects: 32
Study: 11212970

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens alone
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Estrogens plus medroxyprogesterone
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Hormone replacement (both active groups)
Number of subjects: 69
Study: 9609581

Group type: EXPERIMENTAL
Intervention: Oral terbutaline 5 mg every 6 hours for 24 hours
Number of subjects: 6
Study: 8002057

Group type: EXPERIMENTAL
Intervention: KREATECH IgA ELISA test
Number of subjects: 71
Study: 2074253

Group type: EXPERIMENTAL
Intervention: Cefodizime 1.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime 2.0 g
Number of subjects: 0
Study: 415356

Group type: EXPERIMENTAL
Intervention: Mepacrine hydrochloride
Number of subjects: 25

Group type: COMPARATOR
Intervention: Triethylenethiophosphoramide (Thiotepa)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pleurocentesis alone
Number of subjects: 25
Study: 31186173

Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation (prehab group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 70
Study: 31421469

Group type: EXPERIMENTAL
Intervention: TPF induction chemotherapy
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: GP induction chemotherapy
Number of subjects: 189

Group type: COMPARATOR
Intervention: CCRT alone
Number of subjects: 189
Study: 28645713

Group type: EXPERIMENTAL
Intervention: Q6 dosing strategy (n=4)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Q8 dosing strategy (n=6)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Q24 dosing strategy (n=6)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo group (n=10)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Q6 vs Q8
Number of subjects: 26
Study: 25290526

Group type: EXPERIMENTAL
Intervention: Brief smoking cessation intervention
Number of subjects: 354